牛牛AI助理已提取核心訊息
Jin Medical International Ltd., a foreign private issuer, has reported a significant unresolved disagreement with its former registered public accounting firm, DNTW Toronto LLP, concerning the scope of audit procedures for the period between September 23, 2023, and February 25, 2024. The dispute, detailed in a Form 6-K filed with the U.S. Securities and Exchange Commission for April 2024, centers on the audit procedures necessary for DNTW to form an opinion on Jin Medical's financial statements as of September 30, 2023. The disagreement led to DNTW's resignation, citing an impairment of its independence under professional standards. There is also a discrepancy between DNTW and Jin Medical regarding the effective date of the resignation, with DNTW claiming it was February 25, 2024, while Jin Medical asserts it...Show More
Jin Medical International Ltd., a foreign private issuer, has reported a significant unresolved disagreement with its former registered public accounting firm, DNTW Toronto LLP, concerning the scope of audit procedures for the period between September 23, 2023, and February 25, 2024. The dispute, detailed in a Form 6-K filed with the U.S. Securities and Exchange Commission for April 2024, centers on the audit procedures necessary for DNTW to form an opinion on Jin Medical's financial statements as of September 30, 2023. The disagreement led to DNTW's resignation, citing an impairment of its independence under professional standards. There is also a discrepancy between DNTW and Jin Medical regarding the effective date of the resignation, with DNTW claiming it was February 25, 2024, while Jin Medical asserts it was February 26, 2024. Despite discussions by Jin Medical's board of directors, audit committee, and management, no consensus was reached with DNTW. On March 1, 2024, Jin Medical authorized DNTW to respond to inquiries from the successor accountant about the disagreement. The report was signed by Erqi Wang, CEO of Jin Medical International Ltd., on April 12, 2024.
外國私人發行人Jin Medical International Ltd.報告稱，與其前註冊會計師事務所DNTW Toronto LLP在2023年9月23日至2024年2月25日期間的審計程序範圍方面存在重大未解決的分歧。該爭議詳述於2024年4月向美國證券交易委員會提交的6-K表格，其核心是DNTW對Jin Medical截至2023年9月30日的財務報表形成意見所需的審計程序。這種分歧導致DNTW辭職，理由是其在專業標準下的獨立性受到損害。DNTW和金醫療在辭職生效日期方面也存在差異，DNTW聲稱辭職生效日期爲2024年2月25日，而金醫療則聲稱辭職生效日期爲2024年2月26日。儘管金醫療董事會、審計委員會和管理層進行了討論，但沒有與DNTW達成共識。2024年3月1日，金醫療授權DNTW回應繼任會計師關於分歧的詢問。該報告由金醫療國際有限公司首席執行官王爾奇於2024年4月12日簽署。
外國私人發行人Jin Medical International Ltd.報告稱，與其前註冊會計師事務所DNTW Toronto LLP在2023年9月23日至2024年2月25日期間的審計程序範圍方面存在重大未解決的分歧。該爭議詳述於2024年4月向美國證券交易委員會提交的6-K表格，其核心是DNTW對Jin Medical截至2023年9月30日的財務報表形成意見所需的審計程序。這種分歧導致DNTW辭職，理由是其在專業標準下的獨立性受到損害。DNTW和金醫療在辭職生效日期方面也存在差異，DNTW聲稱辭職生效日期爲2024年2月25日，而金醫療則聲稱辭職生效日期爲2024年2月26日。儘管金醫療董事會、審計委員會和管理層進行了討論，但沒有與DNTW達成共識。2024年3月1日，金醫療授權DNTW回應繼任會計師關於分歧的詢問。該報告由金醫療國際有限公司首席執行官王爾奇於2024年4月12日簽署。
有用
沒用